Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Head and Neck Cancer

  Free Subscription


Articles published in Radiother Oncol

Retrieve available abstracts of 117 articles:
HTML format
Text format



Single Articles


    April 2017
  1. YAMASHITA H, Abe O, Nakagawa K
    Involved-field irradiation concurrently combined with nedaplatin/5-fluorouracil for inoperable esophageal cancer on basis of 18FDG-PET scans: A long follow-up results of phase II study.
    Radiother Oncol. 2017 Apr 17. pii: S0167-8140(17)30141.
    PubMed     Text format    


    March 2017
  2. NEVENS D, Duprez F, Daisne JF, Schatteman J, et al
    Recurrence patterns after a decreased dose of 40Gy to the elective treated neck in head and neck cancer.
    Radiother Oncol. 2017 Mar 22. pii: S0167-8140(17)30099.
    PubMed     Text format     Abstract available


  3. LIGTENBERG H, Jager EA, Caldas-Magalhaes J, Schakel T, et al
    Modality-specific target definition for laryngeal and hypopharyngeal cancer on FDG-PET, CT and MRI.
    Radiother Oncol. 2017 Mar 1. pii: S0167-8140(17)30064.
    PubMed     Text format     Abstract available


    February 2017
  4. ZSCHAECK S, Lock S, Leger S, Haase R, et al
    FDG uptake in normal tissues assessed by PET during treatment has prognostic value for treatment results in head and neck squamous cell carcinomas undergoing radiochemotherapy.
    Radiother Oncol. 2017 Feb 17. pii: S0167-8140(17)30047.
    PubMed     Text format     Abstract available


    January 2017
  5. PATEL R, Barker HE, Kyula J, McLaughlin M, et al
    An orally bioavailable Chk1 inhibitor, CCT244747, sensitizes bladder and head and neck cancer cell lines to radiation.
    Radiother Oncol. 2017 Jan 25. pii: S0167-8140(16)34478.
    PubMed     Text format     Abstract available


  6. FUCCIO L, Mandolesi D, Farioli A, Hassan C, et al
    Brachytherapy for the palliation of dysphagia owing to esophageal cancer: A systematic review and meta-analysis of prospective studies.
    Radiother Oncol. 2017 Jan 16. pii: S0167-8140(17)30003.
    PubMed     Text format     Abstract available


    November 2016
  7. THOR M, Owosho AA, Clark HD, Oh JH, et al
    Internal and external generalizability of temporal dose-response relationships for xerostomia following IMRT for head and neck cancer.
    Radiother Oncol. 2016 Nov 24. pii: S0167-8140(16)34380.
    PubMed     Text format     Abstract available


  8. LESZCZYNSKA KB, Dobrynin G, Leslie RE, Ient J, et al
    Preclinical testing of an Atr inhibitor demonstrates improved response to standard therapies for esophageal cancer.
    Radiother Oncol. 2016 Nov 10. pii: S0167-8140(16)34372.
    PubMed     Text format     Abstract available


  9. WANG L, Liu L, Han C, Liu S, et al
    The diffusion-weighted magnetic resonance imaging (DWI) predicts the early response of esophageal squamous cell carcinoma to concurrent chemoradiotherapy.
    Radiother Oncol. 2016 Nov 9. pii: S0167-8140(16)34370.
    PubMed     Text format     Abstract available


    October 2016
  10. QIU B, Wang D, Yang H, Xie W, et al
    Combined modalities of magnetic resonance imaging, endoscopy and computed tomography in the evaluation of tumor responses to definitive chemoradiotherapy in esophageal squamous cell carcinoma.
    Radiother Oncol. 2016 Oct 25. pii: S0167-8140(16)34352.
    PubMed     Text format     Abstract available


  11. MARTINEZ-FERNANDEZ MI, Alcalde J, Cambeiro M, Peydro GV, et al
    Perioperative high dose rate brachytherapy (PHDRB) in previously irradiated head and neck cancer: Results of a phase I/II reirradiation study.
    Radiother Oncol. 2016 Oct 13. pii: S0167-8140(16)34287.
    PubMed     Text format     Abstract available


    August 2016
  12. HE L, Chapple A, Liao Z, Komaki R, et al
    Bayesian regression analyses of radiation modality effects on pericardial and pleural effusion and survival in esophageal cancer.
    Radiother Oncol. 2016 Aug 22. pii: S0167-8140(16)31243.
    PubMed     Text format     Abstract available


  13. NEVENS D, Duprez F, Daisne JF, Dok R, et al
    Reduction of the dose of radiotherapy to the elective neck in head and neck squamous cell carcinoma; a randomized clinical trial. Effect on late toxicity and tumor control.
    Radiother Oncol. 2016 Aug 12. pii: S0167-8140(16)34247.
    PubMed     Text format     Abstract available


  14. CHUTER R, Prestwich R, Bird D, Scarsbrook A, et al
    The use of deformable image registration to integrate diagnostic MRI into the radiotherapy planning pathway for head and neck cancer.
    Radiother Oncol. 2016 Aug 3. pii: S0167-8140(16)31212.
    PubMed     Text format     Abstract available


    July 2016
  15. LOIMU V, Seppala T, Kapanen M, Tuomikoski L, et al
    Diffusion-weighted magnetic resonance imaging for evaluation of salivary gland function in head and neck cancer patients treated with intensity-modulated radiotherapy.
    Radiother Oncol. 2016 Jul 27. pii: S0167-8140(16)31200.
    PubMed     Text format     Abstract available


  16. WONG KH, Kuciejewska A, Sharabiani MT, Ng-Cheng-Hin B, et al
    A randomised controlled trial of Caphosol mouthwash in management of radiation-induced mucositis in head and neck cancer.
    Radiother Oncol. 2016 Jul 5. pii: S0167-8140(16)31174.
    PubMed     Text format     Abstract available


    June 2016
  17. BROUWER CL, Steenbakkers RJ, van der Schaaf A, Sopacua CT, et al
    Selection of head and neck cancer patients for adaptive radiotherapy to decrease xerostomia.
    Radiother Oncol. 2016 Jun 23. pii: S0167-8140(16)31149.
    PubMed     Text format     Abstract available


  18. LIN P, Min M, Lee M, Holloway L, et al
    Prognostic utility of 18F-FDG PET-CT performed prior to and during primary radiotherapy for nasopharyngeal carcinoma: Index node is a useful prognostic imaging biomarker site.
    Radiother Oncol. 2016 Jun 16. pii: S0167-8140(16)31124.
    PubMed     Text format     Abstract available


  19. MATUSCHEK C, Bolke E, Geigis C, Kammers K, et al
    Influence of dosimetric and clinical criteria on the requirement of artificial nutrition during radiotherapy of head and neck cancer patients.
    Radiother Oncol. 2016 Jun 10. pii: S0167-8140(16)31120.
    PubMed     Text format     Abstract available


    May 2016
  20. CHEN CY, Li CC, Chien CR
    Does higher radiation dose lead to better outcome for non-operated localized esophageal squamous cell carcinoma patients who received concurrent chemoradiotherapy? A population based propensity-score matched analysis.
    Radiother Oncol. 2016 May 17. pii: S0167-8140(16)31089.
    PubMed     Text format     Abstract available


  21. KJAER T, Dalton SO, Andersen E, Karlsen R, et al
    A controlled study of use of patient-reported outcomes to improve assessment of late effects after treatment for head-and-neck cancer.
    Radiother Oncol. 2016 May 10. pii: S0167-8140(16)31080.
    PubMed     Text format     Abstract available


  22. JANSSENS GO, Langendijk JA, Terhaard CH, Doornaert PA, et al
    Quality-of-life after radiotherapy for advanced laryngeal cancer: Results of a phase III trial of the Dutch Head and Neck Society.
    Radiother Oncol. 2016 May 7. pii: S0167-8140(16)00111.
    PubMed     Text format     Abstract available


    April 2016
  23. TOL JP, Doornaert P, Witte BI, Dahele M, et al
    A longitudinal evaluation of improvements in radiotherapy treatment plan quality for head and neck cancer patients.
    Radiother Oncol. 2016 Apr 26. pii: S0167-8140(16)31045.
    PubMed     Text format     Abstract available


  24. MOSLEMI D, Nokhandani AM, Otaghsaraei MT, Moghadamnia Y, et al
    Management of chemo/radiation-induced oral mucositis in patients with head and neck cancer: A review of the current literature.
    Radiother Oncol. 2016 Apr 21. pii: S0167-8140(16)31035.
    PubMed     Text format     Abstract available


  25. WANG JZ, Li JB, Qi HP, Li YK, et al
    Effect of contrast enhancement in delineating GTV and constructing IGTV of thoracic oesophageal cancer based on 4D-CT scans.
    Radiother Oncol. 2016;119:172-8.
    PubMed     Text format     Abstract available


  26. DEAN JA, Welsh LC, McQuaid D, Wong KH, et al
    Assessment of fully-automated atlas-based segmentation of novel oral mucosal surface organ-at-risk.
    Radiother Oncol. 2016;119:166-71.
    PubMed     Text format     Abstract available


  27. PALMA B, Bazalova-Carter M, Hardemark B, Hynning E, et al
    Assessment of the quality of very high-energy electron radiotherapy planning.
    Radiother Oncol. 2016;119:154-8.
    PubMed     Text format     Abstract available


  28. TAKANAMI K, Arai A, Umezawa R, Takeuchi T, et al
    Association between radiation dose to the heart and myocardial fatty acid metabolic impairment due to chemoradiation-therapy: Prospective study using I-123 BMIPP SPECT/CT.
    Radiother Oncol. 2016;119:77-83.
    PubMed     Text format     Abstract available


    March 2016
  29. MACFARLANE M, Hoover DA, Wong E, Read N, et al
    Evaluation of unified intensity-modulated arc therapy for the radiotherapy of head-and-neck cancer.
    Radiother Oncol. 2016 Mar 31. pii: S0167-8140(16)31017.
    PubMed     Text format     Abstract available


  30. ELICIN O, Nisa L, Dal Pra A, Bojaxhiu B, et al
    Up-front neck dissection followed by definitive (chemo)-radiotherapy in head and neck squamous cell carcinoma: Rationale, complications, toxicity rates, and oncological outcomes - A systematic review.
    Radiother Oncol. 2016 Mar 17. pii: S0167-8140(16)00125.
    PubMed     Text format     Abstract available


  31. RASMUSSEN JH, Hakansson K, Vogelius IR, Aznar MC, et al
    Phase I trial of 18F-Fludeoxyglucose based radiation dose painting with concomitant cisplatin in head and neck cancer.
    Radiother Oncol. 2016 Mar 15. pii: S0167-8140(16)00127.
    PubMed     Text format     Abstract available


  32. JIN P, Hulshof MC, de Jong R, van Hooft JE, et al
    Quantification of respiration-induced esophageal tumor motion using fiducial markers and four-dimensional computed tomography.
    Radiother Oncol. 2016;118:492-7.
    PubMed     Text format     Abstract available


  33. JANSSENS G, Smeets J, Vander Stappen F, Prieels D, et al
    Sensitivity study of prompt gamma imaging of scanned beam proton therapy in heterogeneous anatomies.
    Radiother Oncol. 2016;118:562-7.
    PubMed     Text format     Abstract available


    February 2016
  34. CHENG Q, Roelofs E, Ramaekers BL, Eekers D, et al
    Development and evaluation of an online three-level proton vs photon decision support prototype for head and neck cancer - Comparison of dose, toxicity and cost-effectiveness.
    Radiother Oncol. 2016 Feb 26. pii: S0167-8140(16)00031.
    PubMed     Text format     Abstract available


  35. HONG A, Zhang X, Jones D, Veillard AS, et al
    Relationships between p53 mutation, HPV status and outcome in oropharyngeal squamous cell carcinoma.
    Radiother Oncol. 2016;118:342-9.
    PubMed     Text format     Abstract available



  36. Beyond mean pharyngeal constrictor dose for beam path toxicity in non-target swallowing muscles: Dose-volume correlates of chronic radiation-associated dysphagia (RAD) after oropharyngeal intensity modulated radiotherapy.
    Radiother Oncol. 2016;118:304-14.
    PubMed     Text format     Abstract available


  37. LYHNE NM, Johansen J, Kristensen CA, Andersen E, et al
    Pattern of failure in 5001 patients treated for glottic squamous cell carcinoma with curative intent - A population based study from the DAHANCA group.
    Radiother Oncol. 2016;118:257-66.
    PubMed     Text format     Abstract available


  38. ROMESSER PB, Cahlon O, Scher E, Zhou Y, et al
    Proton beam radiation therapy results in significantly reduced toxicity compared with intensity-modulated radiation therapy for head and neck tumors that require ipsilateral radiation.
    Radiother Oncol. 2016;118:286-92.
    PubMed     Text format     Abstract available


  39. RICHTER C, Pausch G, Barczyk S, Priegnitz M, et al
    First clinical application of a prompt gamma based in vivo proton range verification system.
    Radiother Oncol. 2016;118:232-7.
    PubMed     Text format     Abstract available


  40. GUJRAL DM, Shah BN, Chahal NS, Bhattacharyya S, et al
    Carotid intima-medial thickness as a marker of radiation-induced carotid atherosclerosis.
    Radiother Oncol. 2016;118:323-9.
    PubMed     Text format     Abstract available


  41. LEE JY, Sun JM, Oh DR, Lim SH, et al
    Comparison of weekly versus triweekly cisplatin delivered concurrently with radiation therapy in patients with locally advanced nasopharyngeal cancer: A multicenter randomized phase II trial (KCSG-HN10-02).
    Radiother Oncol. 2016;118:244-50.
    PubMed     Text format     Abstract available


  42. ZENDA S, Akimoto T, Mizumoto M, Hayashi R, et al
    Phase II study of proton beam therapy as a nonsurgical approach for mucosal melanoma of the nasal cavity or para-nasal sinuses.
    Radiother Oncol. 2016;118:267-71.
    PubMed     Text format     Abstract available


  43. JENSEN AD, Poulakis M, Nikoghosyan AV, Welzel T, et al
    High-LET radiotherapy for adenoid cystic carcinoma of the head and neck: 15 years' experience with raster-scanned carbon ion therapy.
    Radiother Oncol. 2016;118:272-80.
    PubMed     Text format     Abstract available


    January 2016
  44. MESSER JA, Mohamed AS, Hutcheson KA, Ding Y, et al
    Magnetic resonance imaging of swallowing-related structures in nasopharyngeal carcinoma patients receiving IMRT: Longitudinal dose-response characterization of quantitative signal kinetics.
    Radiother Oncol. 2016 Jan 28. pii: S0167-8140(16)00033.
    PubMed     Text format     Abstract available


  45. NYQVIST J, Fransson P, Laurell G, Hammerlid E, et al
    Differences in health related quality of life in the randomised ARTSCAN study; accelerated vs. conventional radiotherapy for head and neck cancer. A five year follow up.
    Radiother Oncol. 2016 Jan 6. pii: S0167-8140(15)00685.
    PubMed     Text format     Abstract available


  46. DONOHOE CL, Reynolds JV
    Letter to the Co-Editors-in-Chief, Radiotherapy and Oncology.
    Radiother Oncol. 2016;118:215.
    PubMed     Text format    


    December 2015
  47. KHAN Z, Khan AA, Prasad GB, Khan N, et al
    Growth inhibition and chemo-radiosensitization of head and neck squamous cell carcinoma (HNSCC) by survivin-siRNA lentivirus.
    Radiother Oncol. 2015 Dec 30. pii: S0167-8140(15)00665.
    PubMed     Text format     Abstract available


  48. DE FELICE F, Musio D, Tombolini V
    Mastication structures definition in head and neck cancer.
    Radiother Oncol. 2015 Dec 29. pii: S0167-8140(15)00677.
    PubMed     Text format    


  49. TAWK B, Schwager C, Deffaa O, Dyckhoff G, et al
    Comparative analysis of transcriptomics based hypoxia signatures in head- and neck squamous cell carcinoma.
    Radiother Oncol. 2015 Dec 19. pii: S0167-8140(15)00647.
    PubMed     Text format     Abstract available


  50. CHRISTIANEN ME, van der Schaaf A, van der Laan HP, Verdonck-de Leeuw IM, et al
    Swallowing sparing intensity modulated radiotherapy (SW-IMRT) in head and neck cancer: Clinical validation according to the model-based approach.
    Radiother Oncol. 2015 Dec 14. pii: S0167-8140(15)00613.
    PubMed     Text format     Abstract available


    November 2015
  51. MOON H, Roh JL, Lee SW, Kim SB, et al
    Prognostic value of nutritional and hematologic markers in head and neck squamous cell carcinoma treated by chemoradiotherapy.
    Radiother Oncol. 2015 Nov 30. pii: S0167-8140(15)00597.
    PubMed     Text format     Abstract available


  52. BUDACH W, Bolke E, Kammers K, Gerber PA, et al
    Induction chemotherapy followed by concurrent radio-chemotherapy versus concurrent radio-chemotherapy alone as treatment of locally advanced squamous cell carcinoma of the head and neck (HNSCC): A meta-analysis of randomized trials.
    Radiother Oncol. 2015 Nov 14. pii: S0167-8140(15)00563.
    PubMed     Text format     Abstract available


    October 2015
  53. SCHWAM ZG, Husain Z, Judson BL
    Refusal of postoperative radiotherapy and its association with survival in head and neck cancer.
    Radiother Oncol. 2015 Oct 24. pii: S0167-8140(15)00555.
    PubMed     Text format     Abstract available


  54. NEVENS D, Deschuymer S, Langendijk JA, Daisne JF, et al
    Validation of the total dysphagia risk score (TDRS) in head and neck cancer patients in a conventional and a partially accelerated radiotherapy scheme.
    Radiother Oncol. 2015 Oct 15. pii: S0167-8140(15)00550.
    PubMed     Text format     Abstract available


  55. DE BREE R, van der Putten L, van Tinteren H, Wedman J, et al
    Effectiveness of an F-FDG-PET based strategy to optimize the diagnostic trajectory of suspected recurrent laryngeal carcinoma after radiotherapy: The RELAPS multicenter randomized trial.
    Radiother Oncol. 2015 Oct 15. pii: S0167-8140(15)00552.
    PubMed     Text format     Abstract available


  56. JIN P, van der Horst A, de Jong R, van Hooft JE, et al
    Marker-based quantification of interfractional tumor position variation and the use of markers for setup verification in radiation therapy for esophageal cancer.
    Radiother Oncol. 2015 Oct 13. pii: S0167-8140(15)00547.
    PubMed     Text format     Abstract available


  57. NESTERUK M, Lang S, Veit-Haibach P, Studer G, et al
    Tumor stage, tumor site and HPV dependent correlation of perfusion CT parameters and [18F]-FDG uptake in head and neck squamous cell carcinoma.
    Radiother Oncol. 2015 Oct 6. pii: S0167-8140(15)00508.
    PubMed     Text format     Abstract available


    September 2015
  58. WIEDENMANN NE, Bucher S, Hentschel M, Mix M, et al
    Serial [18F]-fluoromisonidazole PET during radiochemotherapy for locally advanced head and neck cancer and its correlation with outcome.
    Radiother Oncol. 2015 Sep 29. pii: S0167-8140(15)00473.
    PubMed     Text format     Abstract available


  59. ZACKRISSON B, Kjellen E, Soderstrom K, Brun E, et al
    Mature results from a Swedish comparison study of conventional versus accelerated radiotherapy in head and neck squamous cell carcinoma - The ARTSCAN trial.
    Radiother Oncol. 2015 Sep 29. pii: S0167-8140(15)00506.
    PubMed     Text format     Abstract available


  60. HONING J, Pavlov KV, Mul VE, Karrenbeld A, et al
    CD44, SHH and SOX2 as novel biomarkers in esophageal cancer patients treated with neoadjuvant chemoradiotherapy.
    Radiother Oncol. 2015 Sep 10. pii: S0167-8140(15)00456.
    PubMed     Text format     Abstract available


    August 2015
  61. BASCHNAGEL AM, Wobb JL, Dilworth JT, Williams L, et al
    The association of F-FDG PET and glucose metabolism biomarkers GLUT1 and HK2 in p16 positive and negative head and neck squamous cell carcinomas.
    Radiother Oncol. 2015 Aug 29. pii: S0167-8140(15)00450.
    PubMed     Text format     Abstract available


  62. TANG LL, Chen L, Mao YP, Li WF, et al
    Comparison of the treatment outcomes of intensity-modulated radiotherapy and two-dimensional conventional radiotherapy in nasopharyngeal carcinoma patients with parapharyngeal space extension.
    Radiother Oncol. 2015 Aug 24. pii: S0167-8140(15)00398.
    PubMed     Text format     Abstract available


  63. KUMAR A, Sharma A, Mohanti BK, Thakar A, et al
    A phase 2 randomized study to compare short course palliative radiotherapy with short course concurrent palliative chemotherapy plus radiotherapy in advanced and unresectable head and neck cancer.
    Radiother Oncol. 2015 Aug 21. pii: S0167-8140(15)00380.
    PubMed     Text format     Abstract available


  64. BRUINE DE BRUIN L, Bollineni VR, Wachters JE, Schuuring E, et al
    Assessment of hypoxic subvolumes in laryngeal cancer with F-fluoroazomycinarabinoside (F-FAZA)-PET/CT scanning and immunohistochemistry.
    Radiother Oncol. 2015 Aug 3. pii: S0167-8140(15)00364.
    PubMed     Text format     Abstract available


  65. LIU SL, Yang H, Zhang P, Zhang L, et al
    Neoadjuvant chemoradiotherapy with cisplatin plus vinorelbine versus cisplatin plus fluorouracil for esophageal squamous cell carcinoma: A matched case-control study.
    Radiother Oncol. 2015 Aug 1. pii: S0167-8140(15)00372.
    PubMed     Text format     Abstract available


  66. CHEN YP, Sun Y, Chen L, Mao YP, et al
    Surrogate endpoints for overall survival in combined chemotherapy and radiotherapy trials in nasopharyngeal carcinoma: Meta-analysis of randomised controlled trials.
    Radiother Oncol. 2015 Aug 1. pii: S0167-8140(15)00384.
    PubMed     Text format     Abstract available


    July 2015
  67. ZHANG P, Xi M, Zhao L, Qiu B, et al
    Clinical efficacy and failure pattern in patients with cervical esophageal cancer treated with definitive chemoradiotherapy.
    Radiother Oncol. 2015 Jul 29. pii: S0167-8140(15)00363.
    PubMed     Text format     Abstract available


  68. BEDNAREK C, Crehange G, Quivrin M, Cueff A, et al
    Mapping of failures after radiochemotherapy in patients with non-metastatic esophageal cancer: A posteriori analysis of the dose distribution in the sites of loco-regional relapse.
    Radiother Oncol. 2015 Jul 27. pii: S0167-8140(15)00371.
    PubMed     Text format     Abstract available


  69. HUANG W, Huang Y, Sun J, Liu X, et al
    Atlas of the thoracic lymph nodal delineation and recommendations for lymph nodal CTV of esophageal squamous cell cancer in radiation therapy from China.
    Radiother Oncol. 2015;116:100-6.
    PubMed     Text format     Abstract available


  70. SAMUELS SE, Vainshtein J, Spector ME, Ibrahim M, et al
    Impact of retropharyngeal adenopathy on distant control and survival in HPV-related oropharyngeal cancer treated with chemoradiotherapy.
    Radiother Oncol. 2015;116:75-81.
    PubMed     Text format     Abstract available


  71. KLAASSEN R, Bennink RJ, van Tienhoven G, Bijlsma MF, et al
    Feasibility and repeatability of PET with the hypoxia tracer [(18)F]HX4 in oesophageal and pancreatic cancer.
    Radiother Oncol. 2015;116:94-9.
    PubMed     Text format     Abstract available


    June 2015
  72. BROWN E, Owen R, Harden F, Mengersen K, et al
    Predicting the need for adaptive radiotherapy in head and neck cancer.
    Radiother Oncol. 2015 Jun 30. pii: S0167-8140(15)00318.
    PubMed     Text format     Abstract available


  73. ROZENDAAL RA, Mijnheer BJ, Hamming-Vrieze O, Mans A, et al
    Impact of daily anatomical changes on EPID-based in vivo dosimetry of VMAT treatments of head-and-neck cancer.
    Radiother Oncol. 2015 Jun 30. pii: S0167-8140(15)00283.
    PubMed     Text format     Abstract available


  74. MORRIS ZS, Weichert JP, Saker J, Armstrong EA, et al
    Therapeutic combination of radiolabeled CLR1404 with external beam radiation in head and neck cancer model systems.
    Radiother Oncol. 2015 Jun 26. pii: S0167-8140(15)00297.
    PubMed     Text format     Abstract available


  75. CHENG YK, Zhang F, Tang LL, Chen L, et al
    Pregnancy associated nasopharyngeal carcinoma: A retrospective case-control analysis of maternal survival outcomes.
    Radiother Oncol. 2015 Jun 20. pii: S0167-8140(15)00290.
    PubMed     Text format     Abstract available


  76. MATZINGER O, Viertl D, Tsoutsou P, Kadi L, et al
    The radiosensitizing activity of the SMAC-mimetic, Debio 1143, is TNFalpha-mediated in head and neck squamous cell carcinoma.
    Radiother Oncol. 2015 Jun 18. pii: S0167-8140(15)00270.
    PubMed     Text format     Abstract available


  77. LECLERC M, Lartigau E, Lacornerie T, Daisne JF, et al
    Primary tumor delineation based on FDG PET for locally advanced head and neck cancer treated by chemo-radiotherapy.
    Radiother Oncol. 2015 Jun 15. pii: S0167-8140(15)00288.
    PubMed     Text format     Abstract available


  78. ABBASI AN, Hafiz A, Qureshi BM, Ali N, et al
    Re: Impact of comorbidity in staging & management decision making of nasopharyngeal Ca (NPC).
    Radiother Oncol. 2015;115:435.
    PubMed     Text format    


  79. BROUWER CL, Steenbakkers RJ, Langendijk JA, Sijtsema NM, et al
    Identifying patients who may benefit from adaptive radiotherapy: Does the literature on anatomic and dosimetric changes in head and neck organs at risk during radiotherapy provide information to help?
    Radiother Oncol. 2015;115:285-94.
    PubMed     Text format     Abstract available


  80. TOXOPEUS EL, Nieboer D, Shapiro J, Biermann K, et al
    Nomogram for predicting pathologically complete response after neoadjuvant chemoradiotherapy for oesophageal cancer.
    Radiother Oncol. 2015;115:392-8.
    PubMed     Text format     Abstract available


    May 2015
  81. TAO CJ, Yi JL, Chen NY, Ren W, et al
    Multi-subject atlas-based auto-segmentation reduces interobserver variation and improves dosimetric parameter consistency for organs at risk in nasopharyngeal carcinoma: A multi-institution clinical study.
    Radiother Oncol. 2015 May 26. pii: S0167-8140(15)00247.
    PubMed     Text format     Abstract available


  82. VAN ROSSUM PS, van Lier AL, van Vulpen M, Reerink O, et al
    Diffusion-weighted magnetic resonance imaging for the prediction of pathologic response to neoadjuvant chemoradiotherapy in esophageal cancer.
    Radiother Oncol. 2015 May 19. pii: S0167-8140(15)00236.
    PubMed     Text format     Abstract available


  83. YOU R, Zou X, Hua YJ, Han F, et al
    Salvage endoscopic nasopharyngectomy is superior to intensity-modulated radiation therapy for local recurrence of selected T1-T3 nasopharyngeal carcinoma - A case-matched comparison.
    Radiother Oncol. 2015 May 16. pii: S0167-8140(15)00221.
    PubMed     Text format     Abstract available


  84. BITTERMANN G, Wiedenmann N, Bunea A, Schwarz SJ, et al
    Clipping of tumour resection margins allows accurate target volume delineation in head and neck cancer adjuvant radiation therapy.
    Radiother Oncol. 2015 May 14. pii: S0167-8140(15)00223.
    PubMed     Text format     Abstract available


  85. ZHANG P, Hu X, Yue J, Meng X, et al
    Early detection of radiation-induced heart disease using (99m)Tc-MIBI SPECT gated myocardial perfusion imaging in patients with oesophageal cancer during radiotherapy.
    Radiother Oncol. 2015;115:171-8.
    PubMed     Text format     Abstract available


  86. FORTUNATI V, Verhaart RF, Verduijn GM, van der Lugt A, et al
    MRI integration into treatment planning of head and neck tumors: Can patient immobilization be avoided?
    Radiother Oncol. 2015;115:191-4.
    PubMed     Text format     Abstract available


    April 2015
  87. ZHANG J, Pan L, Ren J, Lang J, et al
    Level IIb CTV delineation based on cervical fascia anatomy in nasopharyngeal cancer.
    Radiother Oncol. 2015;115:46-9.
    PubMed     Text format     Abstract available


  88. YAMAZAKI H, Ogita M, Himei K, Nakamura S, et al
    Carotid blowout syndrome in pharyngeal cancer patients treated by hypofractionated stereotactic re-irradiation using CyberKnife: A multi-institutional matched-cohort analysis.
    Radiother Oncol. 2015;115:67-71.
    PubMed     Text format     Abstract available


  89. VAN DER LAAN HP, Bijl HP, Steenbakkers RJ, van der Schaaf A, et al
    Acute symptoms during the course of head and neck radiotherapy or chemoradiation are strong predictors of late dysphagia.
    Radiother Oncol. 2015;115:56-62.
    PubMed     Text format     Abstract available


    March 2015
  90. TROOST EG, Hoeben BA, Laverman P, Bussink J, et al
    In response to "histopathologic validation of 3'-deoxy-3'-(18)F-fluorothymidine PET for detecting tumour repopulation during fractionated radiotherapy in human FaDu squamous cell carcinoma in nude mice".
    Radiother Oncol. 2015;114:417-8.
    PubMed     Text format    


  91. WOOTEN HO, Rodriguez V, Green O, Kashani R, et al
    Benchmark IMRT evaluation of a Co-60 MRI-guided radiation therapy system.
    Radiother Oncol. 2015;114:402-5.
    PubMed     Text format     Abstract available


    February 2015
  92. JENSEN AD, Poulakis M, Nikoghosyan AV, Chaudhri N, et al
    Re-irradiation of adenoid cystic carcinoma: analysis and evaluation of outcome in 52 consecutive patients treated with raster-scanned carbon ion therapy.
    Radiother Oncol. 2015;114:182-8.
    PubMed     Text format     Abstract available


  93. WANG JZ, Li JB, Wang W, Qi HP, et al
    Changes in tumour volume and motion during radiotherapy for thoracic oesophageal cancer.
    Radiother Oncol. 2015;114:201-5.
    PubMed     Text format     Abstract available


    December 2014
  94. LASSEN P, Primdahl H, Johansen J, Kristensen CA, et al
    Impact of HPV-associated p16-expression on radiotherapy outcome in advanced oropharynx and non-oropharynx cancer.
    Radiother Oncol. 2014;113:310-6.
    PubMed     Text format     Abstract available


  95. LOHAUS F, Linge A, Tinhofer I, Budach V, et al
    HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: results from a multicentre explorative study of the German Cancer Consortium Radiation Oncology Gro
    Radiother Oncol. 2014;113:317-23.
    PubMed     Text format     Abstract available


  96. GUSTER JD, Weissleder SV, Busch CJ, Kriegs M, et al
    The inhibition of PARP but not EGFR results in the radiosensitization of HPV/p16-positive HNSCC cell lines.
    Radiother Oncol. 2014;113:345-51.
    PubMed     Text format     Abstract available


  97. TAKAGI M, Demizu Y, Hashimoto N, Mima M, et al
    Treatment outcomes of particle radiotherapy using protons or carbon ions as a single-modality therapy for adenoid cystic carcinoma of the head and neck.
    Radiother Oncol. 2014;113:364-70.
    PubMed     Text format     Abstract available


  98. WILBERS J, Dorresteijn LD, Haast R, Hoebers FJ, et al
    Progression of carotid intima media thickness after radiotherapy: a long-term prospective cohort study.
    Radiother Oncol. 2014;113:359-63.
    PubMed     Text format     Abstract available


  99. RIOS VELAZQUEZ E, Hoebers F, Aerts HJ, Rietbergen MM, et al
    Externally validated HPV-based prognostic nomogram for oropharyngeal carcinoma patients yields more accurate predictions than TNM staging.
    Radiother Oncol. 2014;113:324-30.
    PubMed     Text format     Abstract available


  100. PARK JW, Nickel KP, Torres AD, Lee D, et al
    Human papillomavirus type 16 E7 oncoprotein causes a delay in repair of DNA damage.
    Radiother Oncol. 2014;113:337-44.
    PubMed     Text format     Abstract available


    November 2014
  101. GRANTZAU T, Overgaard J
    Risk of second non-breast cancer after radiotherapy for breast cancer: A systematic review and meta-analysis of 762,468 patients.
    Radiother Oncol. 2014 Nov 7. pii: S0167-8140(14)00412.
    PubMed     Text format     Abstract available


    September 2014
  102. PANG PP, Hendry J, Cheah SL, Soong YL, et al
    An assessment of the magnitude of intra-fraction movement of head-and-neck IMRT cases and its implication on the action-level of the imaging protocol.
    Radiother Oncol. 2014;112:437-41.
    PubMed     Text format     Abstract available


  103. VISSER R, Wauben DJ, de Groot M, Steenbakkers RJ, et al
    Evaluation of DVH-based treatment plan verification in addition to gamma passing rates for head and neck IMRT.
    Radiother Oncol. 2014;112:389-95.
    PubMed     Text format     Abstract available


  104. JORNET N, Carrasco P, Beltran M, Calvo JF, et al
    Multicentre validation of IMRT pre-treatment verification: comparison of in-house and external audit.
    Radiother Oncol. 2014;112:381-8.
    PubMed     Text format     Abstract available


  105. ROZENDAAL RA, Mijnheer BJ, van Herk M, Mans A, et al
    In vivo portal dosimetry for head-and-neck VMAT and lung IMRT: linking gamma-analysis with differences in dose-volume histograms of the PTV.
    Radiother Oncol. 2014;112:396-401.
    PubMed     Text format     Abstract available


    August 2014
  106. ZHANG H, Tan W, Sonke JJ
    Effect of compressed sensing reconstruction on target and organ delineation in cone-beam CT of head-and-neck and breast cancer patients.
    Radiother Oncol. 2014 Aug 4. pii: S0167-8140(14)00288.
    PubMed     Text format     Abstract available


    July 2014
  107. VAN BOCKEL LW, Verduijn GM, Monninkhof EM, Pameijer FA, et al
    The importance of actual tumor growth rate on disease free survival and overall survival in laryngeal squamous cell carcinoma.
    Radiother Oncol. 2014;112:119-24.
    PubMed     Text format     Abstract available


    May 2014
  108. KOCAK-UZEL E, Gunn GB, Colen RR, Kantor ME, et al
    Beam path toxicity in candidate organs-at-risk: assessment of radiation emetogenesis for patients receiving head and neck intensity modulated radiotherapy.
    Radiother Oncol. 2014;111:281-8.
    PubMed     Text format     Abstract available


    April 2014
  109. SCHUTZE C, Bergmann R, Bruchner K, Mosch B, et al
    Effect of [(18)F]FMISO stratified dose-escalation on local control in FaDu hSCC in nude mice.
    Radiother Oncol. 2014;111:81-7.
    PubMed     Text format     Abstract available


  110. VERHAART RF, Fortunati V, Verduijn GM, van Walsum T, et al
    CT-based patient modeling for head and neck hyperthermia treatment planning: manual versus automatic normal-tissue-segmentation.
    Radiother Oncol. 2014;111:158-63.
    PubMed     Text format     Abstract available


    March 2014
  111. LEE AW, Ng WT, Chan LL, Hung WM, et al
    Evolution of treatment for nasopharyngeal cancer--success and setback in the intensity-modulated radiotherapy era.
    Radiother Oncol. 2014;110:377-84.
    PubMed     Text format     Abstract available


  112. POWELL C, Schick U, Morden JP, Gulliford SL, et al
    Fatigue during chemoradiotherapy for nasopharyngeal cancer and its relationship to radiation dose distribution in the brain.
    Radiother Oncol. 2014;110:416-21.
    PubMed     Text format     Abstract available


    January 2014
  113. TU J, Wang S, Huo Z, Lin Y, et al
    Recombinant human thyrotropin-aided versus thyroid hormone withdrawal-aided radioiodine treatment for differentiated thyroid cancer after total thyroidectomy: a meta-analysis.
    Radiother Oncol. 2014;110:25-30.
    PubMed     Text format     Abstract available


  114. GREGOIRE V, Ang K, Budach W, Grau C, et al
    Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines.
    Radiother Oncol. 2014;110:172-81.
    PubMed     Text format     Abstract available


  115. MOON SH, Cho KH, Chung EJ, Lee CG, et al
    A prospective randomized trial comparing hypofractionation with conventional fractionation radiotherapy for T1-2 glottic squamous cell carcinomas: results of a Korean Radiation Oncology Group (KROG-0201) study.
    Radiother Oncol. 2014;110:98-103.
    PubMed     Text format     Abstract available


  116. DENARO N, Russi EG, Lefebvre JL, Merlano MC, et al
    A systematic review of current and emerging approaches in the field of larynx preservation.
    Radiother Oncol. 2014;110:16-24.
    PubMed     Text format     Abstract available


  117. GUJRAL DM, Chahal N, Senior R, Harrington KJ, et al
    Radiation-induced carotid artery atherosclerosis.
    Radiother Oncol. 2014;110:31-8.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: